Administering 3.5 mL IM Injection: Split-Site Technique
When you need to inject 3.5 mL of ceftriaxone reconstituted with lidocaine intramuscularly, divide the volume between two separate injection sites, administering no more than 3 mL at any single muscle location.
Volume Distribution Strategy
- Split the 3.5 mL total volume into two injections: administer 2 mL at one site and 1.5 mL at a second site 1
- The maximum recommended volume per IM injection site is 3 mL in adults and older children 1
- For infants and younger children, use the anterolateral thigh as the preferred site; for adults and older children, use the deltoid muscle 1
Specific Technique for Ceftriaxone with Lidocaine
- Ceftriaxone 1 g is typically reconstituted in 3.5 mL of 1% lidocaine solution for IM administration 2
- This exact formulation (1 g ceftriaxone in 3.5 mL of 1% lidocaine) has been studied and validated in pharmacokinetic trials 2
- The lidocaine diluent significantly reduces injection pain compared to sterile water, with pain reduction evident immediately after injection and persisting for at least 6 hours 3
- Lidocaine does not alter the pharmacokinetics, bioavailability, or elimination parameters of ceftriaxone 4
Site Selection for Split Dosing
- Choose two separate muscle groups to avoid local tissue irritation from excessive volume 1
- Common combinations include: bilateral deltoids (one in each arm) or one deltoid plus one vastus lateralis (thigh) 1
- Maintain at least 1 inch (2.5 cm) separation between injection sites if using the same muscle group 1
- Use the shortest needle length that reaches intramuscular tissue to minimize pain 1
Administration Technique
- Inject slowly at each site to reduce tissue trauma and pain 1
- Apply concurrent manual pressure to the injection site during administration to decrease discomfort 1
- Use separate syringes for each injection site when splitting the dose 1
Critical Safety Considerations
- Never attempt to inject the full 3.5 mL volume at a single site, as this exceeds safe volume limits and increases risk of tissue damage, poor absorption, and pain 1
- The 1% lidocaine concentration used as diluent is well-tolerated and does not require dose adjustment 4, 5
- Document both injection sites in the medical record 1